A previous study (17) has shown that the gel phase of bovine nasal secretion acts as a natural substrate for parainfluenza-3 virus (PIV-3) neuraminidase. The hypothesis was then put forward (17) that this enzyme promotes virus penetration through the mucociliary barrier by releasing virus from inhibitors in the gel. Consequently, the anti-neuraminidase activity of nasal secretion (NS) would constitute a defence against The present study is concerned with the antibody activity to PIV-3 neuraminidase in the gel and liquid phases of NS from immunized cattle. Since PIV-3 strains are known to differ in their degree of neuraminidase activity (8, 17) , the antigenicity of a "neuraminidase-strong" (NA-S) strain was compared with that of a "neuraminidase-weak" (NA-W) strain. This study was performed to show whether the degree of neuraminidase activity affects the level of the antibody response to neuraminidase.
Immunoglobulin (IG) A has been found to be the major antibody in NS from immunized cattle (15) . In the present study the specificity of virus inhibition by secretory IgA was confirmed by immuno-electronmicroscopy.
MATERIALS AND METHODS
Virus strains and media. The strains Umeg 23, Tubingen-E6, and Norden were used as before (17) . They were propagated for 3 days in monolayer cultures of secondary bovine kidney cells. For strains used for immunization, the maintenance medium was Hanks balanced salt solution with 0.5% lactalbumin hydrolysate and 2%o horse serum. For the Tub E6 strain, which was used in neuraminidase assays, the maintenance medium was Eagle minimal essential medium without serum.
Characteristics of the NA-W strain Um-23. This strain has been described (8, 17) as an NA-W strain. In the assays described here the Um-23 strain had a hemagglutination (HA) titer of 1:1,024 and an infectivity titer of 108 mean tissue culture doses (TCD50) per ml; 0.2 ml of the virus suspension released 0.4 x 10-2 to 0.8 x 102 umol of N-acetylneuraminic acid (NANA) from 200 ,ug of sialolactose in 2 h at 37 C and pH 4.5. Characteristics of the NA-S strain Tub E6. This strain has been described (8, 16) as an NA-S strain. In the assays described here, the Tub-E6 strain had an HA titier of 1:1,024 and an infectivity titer of 108 TCD,dmi; 0.2 ml of the virus suspension released 2.0 x 102 to 3.0 x 10'2 mol of NANA from 200 Mg of sialolactose in 2 h at 37 C and pH 4.5. The Norden strain has also been found to be an NA-S strain (17 Collection and processing of NS and sera. NS was collected by suction from the nose (16) . The samples were kept at -20 C until processed. The liquid phase was separated from the gel by centrifugation for 1 h at 3,000 x g. Further processing consisted of lyophilization of pooled samples of the gel phase (see Results). Sera were separated from blood samples obtained by puncture of the jugular vein and stored at -20 C.
HA and HI tests. These were carried out in a microsystem by using standard equipment (Microtiter Cooke Engineering Co., Alexandria, Va.). In the HI test the samples were tested against 4 HA units of PIV-3. The highest dilution of serum or liquid phase of NS giving complete inhibition of HA was considered as the HI titer.
Neuraminidase assay. This was performed at pH 4.5 as described earlier (8, 17) . The determination of NANA was made spectrophotometrically at 549 nm with correction for other sugar residues at 532 nm by the method of Warren (25) .
NI test. The neuraminidase-inhibition (NI) test was performed essesentially by the method of Ada (1) . A sample of bovine fetal serum from which a sufficient amount of NANA was released by virus was chosen as substrate. The Tub-E6 strain was used as a source of neuraminidase (8, 17) . In the neuraminidase assay the virus concentration used gave a reading between 0.25 and 0.30 at 549 nm of a Beckman spectrophotometer. The time of exposure of substrate (0.2 ml) to virus (0.2 ml) was 4 h at 37 C. The infection titer of the virus suspension used was 108/TCD5,dml.
In NI tests 0.2 ml of a serum or NS dilution was mixed with 0.2 ml of virus and the mixture was incubated at 37 C for 1 h and at 4 C overnight. This mixture was then incubated with substrate for 4 h at 37 C, and the free amount of NANA liberated was corrected for the amount of free NANA present in the virus-substrate mixture prior to incubation. Since serum is a substrate for neuraminidase, each dilution of a serum or NS collected after immunization was compared with the same dilution of serum or NS collected from the same animal before immunization. The NI titer is expressed as the highest dilution of serum or NS which gave a 50% reduction of liberated NANA.
Preparation of secretory IgA. Nasal secretory IgA was prepared from NS of calves as described elsewhere (15, 16) . Lipoproteins were removed by selective adsorption on 0.1% colloidal silicic acid (Aerocil) by the method of Stephan and Roka (24) . NS was freed from impurities and adsorbed material by low-speed centrifugation. IgA was isolated by gel filtration on Sephadex G 200 and ion exchange chromatography on diethylaminoethyl-Sephadex A-50 (19) . Stepwise elution with increasing NaCl concentration was used. IgA eluted at 0.1 M NaCl as evidenced by immunodiffusion, immunoelectrophoresis, and polyacrylamide gel electrophoresis. Analytical ultracentrifugation demonstrated a homogenous population of IgA molecules (15) .
Purification of virus-antibody complexes for transmission electron microscopy. PIV-3, freed of cell debris by low-speed centrifugation at 3,000 x g for 50 min, was incubated with serially diluted IgA at 37 C for 1 h. Neutralization and HI tests were performed in parallel. Samples of PIV-3, showing a total or a partial HI by IgA (12) were concentrated by centrifugation at 100,000 x g for 3 h in a Spinco SW21 rotor. The virus-IgA samples were homogenized and dissolved in 0.5 ml of 0.1 M phosphate buffer, pH 7.2. The preparations were fixed by 1 Intranasal immunization with killed virus. The abilities of an NA-W and an NA-S strain to elicit an increase of antibody activity after i.n. immunization were compared. The results are shown in Table 1 . The NA-W strain induced in two of five calves an HI titer increase in both serum and NS. Three of five calves showed increased NI titers in NS, whereas four of five calves showed increased NI titers in their sera.
The NA-S strain induced in one of five calves an HI titer increase in serum, and in two of five calves in NS. Four of five calves showed an NI titer increase in NS, and four of five calves showed also an NI titer increase in their sera.
Anti-neuraminidase response to two different commercial vaccines. The antibody response to two commercial vaccines, one consisting of the Formalin-killed NA-W strain Um-23 and another of the live NA-S strain Norden, was measured by the HI test, and the results obtained (Table 2 ) have been described elsewhere (16) . The anti-neuraminidase response to these vaccines was measured in the present study. The results obtained (Table 2) show that two s.c. vaccinations with killed NA-W strain induced a 10-fold-higher NI response in serum than in NS. One i.n. instillation of live NA-S strain induced NI titers of the same magnitude in NS and serum. In serum about a threefold-higher NI titer was obtained by two s.c. vaccinations with the killed virus than by a singlle i.n. vaccination with the live virus. In NS, NI titers were about fourfold higher after a single i.n. vaccination with the live virus than after two s.c. vaccinations with the killed virus.
Immuno-electron microscopy. Inhibition of PIV-3 hemagglutinin by NS has been ascribed to antibodies of the IgA class (12, 15, 16) . In the present study we attempted to observe the IgA molecules and PIV-3 particles of a partial as well as a total inhibition. Both participants in inhibition, the IgA and the PIV-3 particle, were first studied each per se (Fig. 3) . The IgA molecules had their elongated, branched morphology (2, 18) . On several PIV-3 particles individual peplomers could be seen.
At a total inhibition by IgA, a broad layer of protein material was observed around the PIV-3 particles (Fig. 4) (Fig. 4) . Occasionally, nonfixed influenza virus elicits increased NI titers in both VOL. 8, 197i 653 serum and NS (5, 6, 9, 23) . A type-specific increase of NI titers was also observed after immunization with some paramyxoviruses (3) .
In the present report a method is described for the measurement of anti-neuraminidase activity to PIV-3 in serum and NS. In the method used in the NI test, the sensitivity towards free NANA does not allow a lower virus dose than 10' TCD50/ml due to the low neuraminidase activity of 17) . Therefore, the comparatively low NI titers obtained must be considered in relation to the large amount of virus to be inhibited in this test system. In general, all animals which responded with a significant rise of HI titers in sera and NS to local, i.e., intranasal, or to systemic immunization, responded also with increased NI titers in these body fluids. The NA-W and NA-S strains showed equal abilities to induce increase of NI titers in serum or NS whether they were applied i.n. or s.c. (Table 1) . Two s.c. doses with 1,600 HAU of either the NA-W or NA-S strain were too low to induce observable increases of NI or HI titers in NS (Table 1 ). In another experiment (Table 2) , two s.c. doses of 8,000 HAU did induce increased NI (16) and NI titers in NS. In our experiments the most effective procedure to induce NI antibody in NS was one i.n. instillation with live PIV-3 ( Table 2 ).
The antibody response as measured by the HI test was observed only occasionally in serum and NS after i.n. immunization with the killed NA-S and NA-W strains ( Immuno-electron microscopy revealed that virus inhibition in NS is caused by the attachment of IgA molecules to the peplomers of PIV-3 (12) and that the number of attached IgA molecules increases with increased inhibition (Fig. 4) . IgA molecules were not attached to portions of the unfixed envelope free from peplomers; this peplomer-free part appears to correspond to the inner layer of the envelope. These rare observations suggest a specific interaction between the IgA molecules and the peplomers of PIV-3.
Recently it has been shown that neuraminidase and HA activities of the paramyxoviruses SV5 (21) and NDV (22) (9, 11) . The discrepancy was assumed to be due to steric hindrance (7, 11) . Concerning PIV-3, it might appear that HI antibodies do inhibit neuraminidase, since the NA-W strain was as efficient in inducing NI antibodies as the NA-S strain. If the neuraminidase is located close to the HA, as appears to be the case with SV5 and NDV (21, 22) , the immunoglobulin molecule directed against HA might, by its size, block the active site of the enzyme. A change of the configuration of the neuraminidase-containing peplomer, caused by the immunoglobulin molecule, could also block the neuraminidase activity. It is also possible that the antigenic determinant for neuraminidase is similar for both the NA-W and NA-S strains despite of the fact that they differ in the degree of neuraminidase activity or that HA and neuraminidase have determinants in common. We do not yet know whether the neuraminidase and HA activities of PIV-3 are located on the same peplomer. Before monospecific antibodies to neuraminidase and HA of PIV-3 are available, it will be difficult to show the importance of cross antibody activity. Regarding influenza viruses, genetic recombination has been used to immunologically distinguish HA from neuraminidase (7, 9, 23) . However, genetic recombination cannot be used for PIV-3 since the strains tested so far have been immunologically similar.
On the way to infect cells of the respiratory tract, PIV-3 has first to penetrate the mucociliary barrier which covers the cells (14) . This barrier consists of two phases (S. Friberg, B. Morein, and L. Rydhag. Amer. Rev. Resp. Dis., in press; reference 14): a superficial gel phase with a liquid phase beneath. The gel phase is rich in NANA (17) bound to glycoproteins, some of which are inhibitors chemically analogous to cell receptors for myxo-and paramyxoviruses (10) . Immune gels inhibited the neuraminidase activity of PIV-3 as compared to gels from nonimmunized animals. Since the release of PIV-3 by neuraminidase from receptors in the gel seems to be a step in the mechanism of penetration through the gel layer (17) , it is reasonable to assume that antibody activity directed against neuraminidase slows down this penetration. This "first line of defence" is dependent on an unimpaired mucociliary system with a normal clearance.
